HCT Following CAR T-Cell Therapy May Improve Patient Outcomes in ALL – Targeted Oncology
Targeted Oncology |
HCT Following CAR T-Cell Therapy May Improve Patient Outcomes in ALL
Targeted Oncology Results of an interim analysis from a small phase I trial presented at the 2018 American Society of Pediatric Hematology/Oncology Conference showed that CAR T-cell therapy can induce next generation sequencing (NGS) negativity in patients with relapsed … |
